MSB 2.03% $1.45 mesoblast limited

2024 Here we go again., page-591

  1. 4,203 Posts.
    lightbulb Created with Sketch. 5498
    They have an EAP for adults, so perhapse a trial is not needed, if they can generate the patient numbers using real world evidence. - Thanks to the update to the regulations placing more focus on real world evidence than previously.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.